These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 8722625
1. Regulation of plasminogen activator in rat endometrial stromal cells: the role of prostaglandin E2. Zhang X, Shu MA, Ross HE, Kennedy TG. Biol Reprod; 1996 May; 54(5):1046-51. PubMed ID: 8722625 [Abstract] [Full Text] [Related]
12. Gelatinases A and B and tissue inhibitors of metalloproteinases 1, 2, and 3 during in vivo and in vitro decidualization of rat endometrial stromal cells. Nuttall RK, Kennedy TG. Biol Reprod; 1999 Feb; 60(2):471-8. PubMed ID: 9916016 [Abstract] [Full Text] [Related]
13. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor. Levenson AS, Kwaan HC, Svoboda KM, Weiss IM, Sakurai S, Jordan VC. Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256 [Abstract] [Full Text] [Related]
14. Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis. Sandberg T, Casslén B, Gustavsson B, Benraad TJ. Biol Reprod; 1998 Oct; 59(4):759-67. PubMed ID: 9746723 [Abstract] [Full Text] [Related]
15. Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor. Casslén B, Nordengren J, Gustavsson B, Nilbert M, Lund LR. J Clin Endocrinol Metab; 1995 Sep; 80(9):2776-84. PubMed ID: 7673423 [Abstract] [Full Text] [Related]
16. Quantitative evaluation of the influence of ovarian steroids on plasminogen activators and inhibitors in human endometrial cells and trophoblasts. Ueyama M, Kasatori N, Urayama T, Maemura T, Yao Y, Shiraishi T, Saito S, Kubo H. Thromb Res; 2002 Nov 25; 108(4):235-44. PubMed ID: 12617987 [Abstract] [Full Text] [Related]
17. Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin. Iwamoto J, Takahashi K, Mizokami Y, Otsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokoube K, Matsuoka T. Dig Dis Sci; 2003 Dec 25; 48(12):2247-56. PubMed ID: 14714609 [Abstract] [Full Text] [Related]
18. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ. J Cell Physiol; 1991 Oct 25; 149(1):34-43. PubMed ID: 1834680 [Abstract] [Full Text] [Related]
19. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2. Liu JW, Wei DZ, Du CB, Zhong JJ. Acta Pharmacol Sin; 2003 Feb 25; 24(2):102-8. PubMed ID: 12546716 [Abstract] [Full Text] [Related]
20. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells. Lockwood CJ. Am J Obstet Gynecol; 2001 Apr 25; 184(5):798-804; discussion 804-5. PubMed ID: 11303186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]